Engineered probiotics introduced to improve intestinal microecology for the treatment of chronic diseases: present state and perspectives
ConclusionThis review summarizes the application of synthetic biology in intestinal microecology-based therapeutics for major chronic diseases and discusses the opportunities and challenges in the above process, providing clinical possibilities of synthetic biology technology applied in microecological therapies.
Source: Journal of Diabetes and Metabolic Disorders - Category: Endocrinology Source Type: research
More News: Alzheimer's | Biology | Brain | Cancer | Cancer & Oncology | Colorectal Cancer | Diabetes | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Inflammatory Bowel Disease | Liver | Liver Disease | Liver Transplant | Neurology | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Phenylketonuria | Probiotics | Study | Transplants | Urology & Nephrology